ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
AB Corporate Bond ETF

AB Corporate Bond ETF (EYEG)

35.445
0.065
(0.18%)
Cerrado 25 Diciembre 3:00PM
35.445
0.00
(0.00%)
Fuera de horario: 4:00PM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
35.445
Postura de Compra
32.00
Postura de Venta
38.94
Volume Operado de la Acción
2
35.445 Rango del Día 35.445
34.52 Rango de 52 semanas 37.24
Capitalización de Mercado [m]
Precio Anterior
35.38
Precio de Apertura
35.445
Última hora de negociación
Volumen financiero
US$ 71
Precio Promedio Ponderado
35.445
Volumen promedio (3 m)
3,102
Acciones en circulación
7,689,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-1.92
Beneficio por acción (BPA)
-1.7
turnover
-
Beneficio neto
-13.05M

Acerca de AB Corporate Bond ETF

The Fund is an actively-managed exchange-traded fund (ETF). The Fund pursues its objective by investing, under normal circumstances, at least 80% of its net assets, including any borrowings for investment purposes, in investment grade fixed-income securities of corporate issuers. Corporate issuers m... The Fund is an actively-managed exchange-traded fund (ETF). The Fund pursues its objective by investing, under normal circumstances, at least 80% of its net assets, including any borrowings for investment purposes, in investment grade fixed-income securities of corporate issuers. Corporate issuers may include corporate or other business entities in which a sovereign or governmental agency or entity may have, indirectly or directly, an interest, including a majority or greater ownership interest. The Funds investment objective is to maximize total return through current income and longterm capital appreciation. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
AB Corporate Bond ETF is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker EYEG. The last closing price for AB Corporate Bond ETF was US$35.38. Over the last year, AB Corporate Bond ETF shares have traded in a share price range of US$ 34.52 to US$ 37.24.

AB Corporate Bond ETF currently has 7,689,000 shares in issue. The market capitalisation of AB Corporate Bond ETF is US$272.04 million. AB Corporate Bond ETF has a price to earnings ratio (PE ratio) of -1.92.

EYEG Últimas noticias

EyeGate Pharmaceuticals to Present at BIO CEO & Investor Conference in New York City

WALTHAM, Mass., Jan. 29, 2019 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today announced that the Company will attend and present at the 21st...

EyeGate Pharmaceuticals Announces Meeting Date with FDA

WALTHAM, Mass., Jan. 16, 2019 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today confirmed that it is scheduled to meet with the U.S. Food and...

EyeGate Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update

WALTHAM, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) (“EyeGate” or “the Company”) today announced financial results for the three-month period ended...

EyeGate Pharma Announces Positive Results in Second PRK Study

Data confirms results from earlier study WALTHAM, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) today announced top-line data from its study evaluating...

EyeGate Pharmaceuticals Signs Technology Transfer and License Agreement with SentrX Animal Care

WALTHAM, Mass., Oct. 02, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Pharmaceuticals Granted Additional 180 Days to Comply With Nasdaq Listing Rules

WALTHAM, Mass., Sept. 25, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Pharmaceuticals Completes Enrollment in Both PRK and PE Pilot Studies

WALTHAM, Mass., Sept. 24, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Announces Randomization of First Patients in Study for Punctate Epitheliopathies

WALTHAM, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

EyeGate Announces Top-Line Results for Phase 3 Trial of EGP-437 in Anterior Uveitis

WALTHAM, Mass., Sept. 04, 2018 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) a clinical-stage, specialty pharmaceutical company with two proprietary platform technologies for...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.38-1.0607117934435.82535.8735.37652435.50931308SP
4-0.575-1.5963353692436.0236.4135.37789735.95752914SP
12-1.535-4.1508923742636.9836.9835.37310236.02910236SP
26-0.145-0.40741781399335.5937.2435.0184179036.11787382SP
52-0.515-1.4321468298135.9637.2434.52110835.92413648SP
1560.2450.69602272727335.237.2434.52109635.92330783SP
2600.2450.69602272727335.237.2434.52109635.92330783SP

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
BAOSBaosheng Media Group Holdings Ltd
US$ 7.10
(310.40%)
58.74M
HOURHour Loop Inc
US$ 4.40
(207.69%)
97.42M
GTIGraphjet Technology
US$ 0.61
(168.72%)
265.48M
CREVCarbon Revolution Public Ltd
US$ 9.16
(135.48%)
26.95M
AVGRAvinger Inc
US$ 1.45
(125.72%)
107.53M
SLGLSol Gel Technologies Ltd
US$ 0.9798
(-40.62%)
3.07M
DRCTDirect Digital Holdings Inc
US$ 3.71
(-32.55%)
23.82M
CHEKCheck Cap Ltd
US$ 1.55
(-31.11%)
3.49M
SYTASiyata Mobile Inc
US$ 0.5178
(-30.83%)
2.63M
BTFValkyrie ETF Trust II CoinShares Bitcoin and Ether Stratagy ETF
US$ 15.47
(-30.38%)
147.98k
SVMHSRIVARU Holding Ltd
US$ 0.0338
(20.71%)
280.27M
GTIGraphjet Technology
US$ 0.61
(168.72%)
265.48M
LITMSnow Lake Resources Ltd
US$ 0.5849
(52.84%)
181.22M
LCIDLucid Group Inc
US$ 3.20
(3.23%)
108.75M
RGTIRigetti Computing Inc
US$ 11.35
(3.56%)
108.38M
cjstocksup cjstocksup 6 minutos hace
https://x.com/elonmusk/status/1871980130303918426
QueenVic QueenVic 6 minutos hace
🎄🎄🎄🎄🎄
FMCC
Juntao Juntao 6 minutos hace
$10 🚀🚀🚀🚀
AUTR
cjstocksup cjstocksup 6 minutos hace
https://x.com/elonmusk/status/1871945958420004943
xxxx xxxx 7 minutos hace
ALL ARE WELCOMED !!!

THE CHOICE ?

EASY











SIMPLE, walk thru or bang your head on the door.
SHIBUSD
skitahoe skitahoe 8 minutos hace
My first investment experience, which I mentioned, was a lesson I hope people here will recognize. As I mentioned, my father put me in a stock, back then they were listed daily in the newspaper, and I routinely watched it. I saw if fall to a small fraction of what it was when he bought it, then ri
NWBO
dukeb dukeb 10 minutos hace
A few years ago I made the trek to meet an old friend at a well reviewed Bangladeshi restaurant.

Friend and I shared two huge platters of food. One vegetarian and the other with meat. Each platter was covered in a spongy Bangladeshi bread with piles of various foods in little stacks
Zorax Zorax 11 minutos hace
Only Ramen thing I've ever had comes in plastic packages with little foil pillows of stuff and takes 3 minutes to microwave.

EDIT: Didn't see Janice's later post.
caddiedad caddiedad 14 minutos hace
As seen on Twits:

$AMRN
Amarin Patent Issued
Great news for heart health! ❤️ Amarin's patent for EPA to lower triglycerides in statin-treated patients is officially issued!
https://sih-st-charts.stocktwits-cdn.com/fit-in/300x0/filters:quality(75)/production/orig
AMRN
Drugdoctor Drugdoctor 14 minutos hace
George is Jewish, Hannukah is just starting...
WNFT
QueenVic QueenVic 14 minutos hace
Check this out...

The POS from Scranton is getting a downgrade...Removing the name from the Expressway! Let's hope more of those Dem people from WOKE get a permanent downgrade

https://www.foxnews.com/politics/pa-lawmakers-scranton-biden-expy-scar-kids-4-cash-scandal
dukeb dukeb 15 minutos hace
When the story first appeared I read some of the most popular comments and they echoed much of what you said.

On a different note, an article popped up on my Google News feed about the best Cheesesteaks from fast food joints.

https://www.eatthis.com/fast-food-cheesest
dewophile dewophile 17 minutos hace
Enta did say they feel a jury should decide on the matter in question. I would feel pretty good about a jury agreeing it was a mistake. You always want the broadest (defendable) patent so including C2-12 and not C1 seems obvious.
They would then have to battle PFE over whether or not paxlovi
PFE
Lurker3 Lurker3 17 minutos hace
Shareholder value decreased with 80%
LWLG
threewheeler threewheeler 18 minutos hace
FDCTech acquired 51% equity stake in AD Advisory Services Pty Ltd, an Australian wealth mangement company with 20 offices, 28 advisors, $530+ million funds under advice. In 2024, FDCTech has successfully acquired and integrated Alchemy Markets, a leading EU brokerage, and Alchemy Prime, a prominent
FDCT
dewophile dewophile 20 minutos hace
Yes if they succeed in getting the appeals court or a jury or the patent office to side with them that excluding the C1 was an obvious mistake that juts puts the patent back in play. The next battle would be over infringement
davidsson10 davidsson10 21 minutos hace
I needed a refresher:

https://www.thesaurus.com/e/grammar/s/serial-comma/#do-you-call-it-the-serial-comma-or-the-oxford-comma
ohsaycanyousee82 ohsaycanyousee82 23 minutos hace
Time to sing a different tune, Kund.

https://m.youtube.com/watch?v=vWdnI4lZIN8
AVXL
cardmaster114 cardmaster114 23 minutos hace
Merry Christmas and Happy New Year to all shareholders and posters. May you be healthy and wealthy in the upcoming new year !!!!
DBMM
Paulie Cashews Paulie Cashews 27 minutos hace
Thanks! I got a sweater for Christmas.

I wanted a screamer or a moaner.

adserv.stocksite.com/images/paulie/xmaslinda1.jpg

www.investorshub.com/boards/plustrees.asp?board_id=2581 Paulie's Pixel Palace
nwtf nwtf 31 minutos hace
Ahhh the old pee wee herman defense. """I know what Iam but what are you????"""

Thats pretty lame. But no matter how many times YOU keep telling your lies it will not make it true.

Everyone knows who the hucksters are. You wear that hat well.
ERHE
Mr. Dragon Mr. Dragon 32 minutos hace
At this special time of year, when people are most generous, it's a shame to know that shysters and conmen will continue to run their scams.
DPLS
crazy horse 0 crazy horse 0 36 minutos hace
Multiple injured after car plows into pedestrians in NY Herald Square

https://mol.im/a/14226357
Peter J Peter J 38 minutos hace
Mr. beat around the bush,

Stop beating around the bush. You are a con man, who does not want to address that other con man with 14.000 posts.

I told you already that the fact that you are right about Krombacher, DOES NOT MEAN THAT YOU CAN IGNORE the con man with 14.00
ERHE

Su Consulta Reciente

Delayed Upgrade Clock